Test Price
2,800 AEDโ Home Collection Available
VLDLR Gene: Cerebellar Hypoplasia & Mental Retardation with or Without Quadrupedal Locomotion โ Genetic Test in UAE | 2800 AED | DNA Labs UAE | DHA Licensed
Executive Summary & Core Metrics
The VLDLR gene Next-Generation Sequencing (NGS) test provides comprehensive analysis of the VLDLR gene to detect pathogenic variants associated with autosomal recessive cerebellar hypoplasia, intellectual disability, and quadrupedal locomotion. This test offers 99.9% diagnostic sensitivity and is performed in our ISO 9001:2015 accredited laboratory (Cert: INT/EGQ/2509DA/3139) under DHA supervision. We provide VIP mobile phlebotomy and temperature-controlled cold-chain home collection services daily from 8 AM to 11 PM, along with telephonic post-test genetic counseling by DHA-licensed professionals. Direct billing verification is available via WhatsApp +971 54 548 8731 for all major UAE insurers.
- โ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- โ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, 8 AM โ 11 PM.
- โ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with DHA-licensed genetic counselling.
- โ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731. All major UAE insurers accepted.
Test Overview & Methodology
The VLDLR gene NGS test identifies pathogenic variants causing autosomal recessive cerebellar hypoplasia, intellectual disability, and quadrupedal gait. This advanced sequencing technology ensures comprehensive coverage of all coding regions, splice sites, and regulatory elements, enabling early diagnosis and family planning.
| Feature | Our Test โ Premium NGS | Closest Alternative โ Single-Gene Sanger |
|---|---|---|
| Diagnostic Precision | 99.9% (full gene, deep coverage) | ~95% (limited to known hotspots) |
| Methodology | NGS (Next Generation Sequencing) with CNV analysis | Sanger sequencing, exon by exon |
| Turnaround Time | 3 to 4 weeks | 4 to 6 weeks |
| Sample Options | Whole Blood, Dried Blood Spot (FTA Card), Extracted DNA | Blood or DNA, limited card acceptance |
Physician Insight & Safety Protocols
โThis genetic test provides a molecular window into a complex neurodevelopmental phenotype. It must be interpreted in the context of a comprehensive neurological and developmental evaluation. A negative result does not rule out other genetic causes, while a positive finding demands correlation with clinical presentation and cascade family testing under the guidance of a medical geneticist.โ
โ Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
โ ๏ธ Do not discontinue any prescribed medication without first consulting your treating physician. The results of this genetic test are intended to inform clinical decision-making, not replace ongoing therapeutic management.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Recent blood transfusion (<2 weeks), heparinized sample (use EDTA only), dried blood spot card improperly stored; test not recommended for prenatal diagnosis unless amniocentesis is clinically indicated and discussed with a fetal medicine specialist.
- Emergency Red Flags: If the patient experiences new-onset seizures, acute neurological deterioration, severe feeding difficulties, or loss of previously acquired motor skills, seek immediate medical evaluation at the nearest DHA/MOHAP-licensed emergency department. Do not wait for genetic test results.
Patient FAQ & Clinical Guidance
1. What is the VLDLR gene test, and why is it performed?
The VLDLR gene test uses next-generation sequencing to detect pathogenic variants causing autosomal recessive cerebellar hypoplasia and intellectual disability, guiding clinical diagnosis and genetic counselling for families.
2. How is the sample collected, and how long until I receive the results?
A certified phlebotomist collects a blood sample, one drop of blood on an FTA card, or extracted DNA at your home; results are issued within 3 to 4 weeks, with optional expedited reports.
3. Is this genetic test covered by UAE health insurance?
We verify direct billing eligibility with major UAE insurers via WhatsApp +971 54 548 8731, offering a seamless payment experience before testing; most policies cover diagnostically necessary genetic testing.
UAE Regulatory & Data Privacy Adherence
This test is performed in strict adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient safety and informed consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE operates under DHA Facility License 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | VLDLR Gene Sequencing (Cerebellar Hypoplasia & Mental Retardation with or Without Quadrupedal Locomotion) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole Blood, Dried Blood Spot (FTA Card), or Extracted DNA |
| Methodology Used | Next Generation Sequencing (NGS) with CNV analysis |
| ICD-10-CM Code | G11.8, F78.9, Z15.09 |
| LOINC Code | 94133-1 |
| DHA Facility License & Laboratory Address | DHA License 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians